AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Part of paid clinical trials in Anniston, Alabama.
- Sponsor
- Novo Nordisk A/S
- Study ID
- NCT07503210
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NNC0487-0111 — DRUGNNC0487-0111 will be administered subcutaneously.
- Placebo (matched to NNC0487-0111) — DRUGPlacebo will be administered subcutaneously.
Study Details
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Key Dates
- Start date
- Apr 21, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 6, 2028
- Completion
- Jul 4, 2028
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: NNC0487-0111Participants will receive subcutaneous injection of NNC0487-0111 once weekly as an adjunct to a reduced-calorie diet and increased physical activity.
- Placebo Comparator: PlaceboParticipants will receive subcutaneous injection of placebo matched to NNC0487-0111 once weekly as an adjunct to a reduced-calorie diet and increased physical activity.
Primary Outcome Measure
Relative change in body weight [ Time Frame: From week 40 to week 92 ]
Central Contacts
- Novo Nordisk(+1) 866-867-7178
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pinnacle Research Group LLC | Anniston | Alabama | 36207 | - |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | - |
| Florida Inst For Clin Res LLC | Orlando | Florida | 32825 | - |
| Endeavor Health | Skokie | Illinois | 60077 | - |
| Midwest Inst For Clin Res | Indianapolis | Indiana | 46260 | - |
| Medication Mgmnt, LLC_Grnsboro | Greensboro | North Carolina | 27405 | - |
| PMG Research of Wilmington LLC | Wilmington | North Carolina | 28401 | - |
| UPA Ctr Weight and Eating Dis | Philadelphia | Pennsylvania | 19104 | - |
| Clinical Res Collaborative | Cumberland | Rhode Island | 02864 | - |
| North Texas Endocrine Center | Dallas | Texas | 75231 | - |
| UT Southwestern Med Cntr | Dallas | Texas | 75390-9302 | - |
| Selma Medical Associates | Winchester | Virginia | 22601-3834 | - |
| Rainier Clin Res Ctr Inc | Renton | Washington | 98057 | - |
Find similar trials in Anniston, AL
By condition
By specialty
Related Studies
- Investigating the Impact of Obesity on Pubertal Development in GirlsRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- DNA Methylation and Vascular FunctionRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesPHASE2 · Recruiting · University of Colorado, Denver · Durham, North Carolina